Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma

This study has been completed.

Study NCT00006232 Information provided by National Cancer Institute (NCI)

First Received: September 11, 2000 Last Updated: August 23, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Additional conditions recognized in this trial

Multiple Myeloma
Neoplasms
Neoplasms, Plasma Cell

More general conditions related to this trial

Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Paraproteinemias
Vascular Diseases

Interventions listed in this trial

dexamethasone
doxorubicin hydrochloride
idarubicin
vincristine sulfate

Additional drug interventions recognized in this trial

Dexamethasone acetate
Doxorubicin
Vincristine

Sponsors listed in this trial

West of Scotland Lymphoma Group

Back to top of Main Content